Vnitr Lek 2010, 56(3):220-225

Myocardial dysfunction in sepsis - definition and pathogenetic mechanisms

K. Muriová*, J. Maláska, F. Otevřel, M. Slezák, M. Kratochvíl, P. Ševčík
Klinika anesteziologie, resuscitace a intenzivní medicíny Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Pavel Ševčík, CSc.

Sepsis is considered to be the major cause of morbidity and mortality of patients hospitalised in intensive care. It's defined as a systemic inflammatory response of organism to infection. Incidence of myocardial dysfunction in studies with severe sepsis patients is up to two thirds of patients. Cardiac dysfunction shows a continuum from isolated and mild diastolic dysfunction to combined severe diastolic and systolic failure of both ventricles mimicking even cardiogenic shock in some patients. Typical features of septic myocardial dysfunction (SMD) are decrease in ejection fraction (EF) with dilatation of ventricles, e. g. increase in end-diastolic volume (EDV). Reversibility of myocardial dysfunction during a period from 7 to 10 days in survivors is other typical manifestation of SMD. Hence, one can speculate that development of such a type of SMD as a temporary protective compensatory mechanism could be advantageous for of an individual patient. A large body of evidence about mechanisms of SMD was described; endothelial dysfunction with consequent microcirculatory and mitochondrial dysfunction and role of circulating factors are considered to be the most important.

Keywords: sepsis; myocardial dysfunction; endothelium; cytokines; NO; mitochondria; troponin; BNP

Received: October 21, 2009; Accepted: January 25, 2010; Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Muriová K, Maláska J, Otevřel F, Slezák M, Kratochvíl M, Ševčík P. Myocardial dysfunction in sepsis - definition and pathogenetic mechanisms. Vnitr Lek. 2010;56(3):220-225.
Download citation

References

  1. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310. Go to original source... Go to PubMed...
  2. Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554. Go to original source... Go to PubMed...
  3. Vincent JL, Sakr Y, Sprung CL et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353. Go to original source... Go to PubMed...
  4. Gupta A, Brahmbhatt S, Kapoor R et al. Chronic peritoneal sepsis: myocardial dysfunction, endothelin and signaling mechanisms. Front Biosci 2005; 10: 3183-3205. Go to original source... Go to PubMed...
  5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150. Go to original source... Go to PubMed...
  6. Waisbren BA. Bacteremia due to gram-negative bacilli other than the Salmonella; a clinical and therapeutic study. AMA Arch Intern Med 1951; 88: 467-488. Go to original source... Go to PubMed...
  7. Belcher E, Mitchell J, Evans T. Myocardial dysfunction in sepsis: no role for NO? Heart 2002; 87: 507-509. Go to original source... Go to PubMed...
  8. Maeder M, Fehr T, Rickli H et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129: 1349-1366. Go to original source... Go to PubMed...
  9. Parker MM, Shelhamer JH, Bacharach SL et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100: 483-490. Go to original source... Go to PubMed...
  10. Parker MM, McCarthy KE, Ognibene FP et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97: 126-131. Go to original source... Go to PubMed...
  11. Poelaert J, Declerck C, Vogelaers D et al. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23: 553-560. Go to original source... Go to PubMed...
  12. Vieillard-Baron A, Caille V, Charron C et al. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36: 1701-1706. Go to original source... Go to PubMed...
  13. Hinshaw LB, Archer LT, Spitzer JJ et al. Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 1974; 227: 1051-1057. Go to original source... Go to PubMed...
  14. Hotchkiss RS, Rust RS, Dence CS et al. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker 18Ffluoromisonidazole. Am J Physiol 1991; 261: R965-R972. Go to original source... Go to PubMed...
  15. Cunnion RE, Schaer GL, Parker MM et al. The coronary circulation in human septic shock. Circulation 1986; 73: 637-644. Go to original source... Go to PubMed...
  16. Mebazaa A, De Keulenaer GW, Paqueron X et al. Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide. Circulation 2001; 104: 3137-3144. Go to original source... Go to PubMed...
  17. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007; 35: 1599-1608. Go to original source... Go to PubMed...
  18. Zhu X, Bernecker OY, Manohar NS et al. Increased leakage of sarcoplasmic reticulum Ca2+ contributes to abnormal myocyte Ca2+ handling and shortening in sepsis. Crit Care Med 2005; 33: 598-604. Go to original source... Go to PubMed...
  19. Larche J, Lancel S, Hassoun SM et al. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol 2006; 48: 377-385. Go to original source... Go to PubMed...
  20. Brealey D, Karyampudi S, Jacques TS et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286: R491-R497. Go to original source... Go to PubMed...
  21. Levy RJ, Deutschman CS. Cytochrome c oxidase dysfunction in sepsis. Crit Care Med 2007; 35 (9 Suppl): S468-S475. Go to original source... Go to PubMed...
  22. Suliman HB, Welty-Wolf KE, Carraway M et al. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 2004; 64: 279-288. Go to original source... Go to PubMed...
  23. Murray AJ, Anderson RE, Watson GC et al. Uncoupling proteins in human heart. Lancet 2004; 364: 1786-1788. Go to original source... Go to PubMed...
  24. Hotchkiss R, Nunnally I, Lindquist S et al. Hyperthermia protects mice against the lethal effects of endotoxin. Am J Physiol 1993; 265: R1447-R1457. Go to original source... Go to PubMed...
  25. Das DK, Maulik N. Mitochondrial function in cardiomyocytes: target for cardioprotection. Curr Opin Anaesthesiol 2005; 18: 77-82. Go to original source... Go to PubMed...
  26. Carlson DL, Horton JW. Cardiac molecular signaling after burn trauma. J Burn Care Res 2006; 27: 669-675. Go to original source... Go to PubMed...
  27. Wu LL, Yang SL, Yang RC et al. G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock 2003; 19: 533-537. Go to original source... Go to PubMed...
  28. Annane D, Trabold F, Sharshar T et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 1999; 160: 458-465. Go to original source... Go to PubMed...
  29. Macarthur H, Westfall TC, Riley DP et al. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000; 97: 9753-9758. Go to original source... Go to PubMed...
  30. Bohm M, Kirchmayr R, Gierschik P et al. Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med 1995; 98: 183-186. Go to original source... Go to PubMed...
  31. Schmidt HB, Werdan K, Muller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 2001; 7: 314-322. Go to original source... Go to PubMed...
  32. Kumar A, Bunnell E, Lynn M et al. Experimental human endotoxemia is associated with depression of load-independent contractility indices: prevention by the lipid an analogue E5531. Chest 2004; 126: 860-867. Go to original source... Go to PubMed...
  33. Tavener SA, Long EM, Robbins SM et al. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia. Circ Res 2004; 95: 700-707. Go to original source... Go to PubMed...
  34. Knuefermann P, Sakata Y, Baker JS et al. Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 2004; 110: 3693-3698. Go to original source... Go to PubMed...
  35. Reilly AM, Sun X, Williams DA et al. Dexamethasone inhibits endotoxin-induced changes in calcium and contractility in rat isolated papillary muscle. Cell Calcium 1999; 26: 1-8. Go to original source... Go to PubMed...
  36. Parrillo JE, Burch C, Shelhamer JH et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76: 1539-1553. Go to original source... Go to PubMed...
  37. Pathan N, Hemingway CA, Alizadeh AA et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363: 203-209. Go to original source... Go to PubMed...
  38. Meng X, Ao L, Meldrum DR et al. TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 1998; 275: R502-R508. Go to original source... Go to PubMed...
  39. Kadokami T, McTiernan CF, Kubota T et al. Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. Am J Physiol Heart Circ Physiol 2001; 280: H2281-H2291. Go to original source... Go to PubMed...
  40. Piper RD. Myocardial dysfunction in sepsis. Clin Exp Pharmacol Physiol 1998; 25: 951-954. Go to original source... Go to PubMed...
  41. Sharma AC. Sepsis-induced myocardial dysfunction. Shock 2007; 28: 265-269. Go to original source... Go to PubMed...
  42. Dinarello CA. Interleukin-1beta. Crit Care Med 2005; 33 (12 Suppl): S460-S462. Go to original source... Go to PubMed...
  43. Reinhart K, Bayer O, Brunkhorst F et al. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002; 30 (5 Suppl): S302-S312. Go to original source... Go to PubMed...
  44. Calandra T, Echtenacher B, Roy DL et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164-170. Go to original source... Go to PubMed...
  45. Chagnon F, Metz CN, Bucala R et al. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 2005; 96: 1095-1102. Go to original source... Go to PubMed...
  46. Fernandes CJ Jr., Akamine N, Knobel E. Myocardial depression in sepsis. Shock 2008; 30 (Suppl 1): 14-17. Go to original source... Go to PubMed...
  47. Massion PB, Moniotte S, Balligand JL. Nitric oxide: does it play a role in the heart of the critically ill? Curr Opin Crit Care 2001; 7: 323-336. Go to original source... Go to PubMed...
  48. Price S, Anning PB, Mitchell JA et al. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J 1999; 20: 715-724. Go to original source... Go to PubMed...
  49. Steendijk P. The role of inducible nitric oxide synthase in the evolution of myocardial (dys)function during resuscitated septic shock: the missing loop. Crit Care Med 2006; 34: 545-547. Go to original source... Go to PubMed...
  50. Flierl MA, Rittirsch D, Huber-Lang MS et al. Molecular events in the cardiomyopathy of sepsis. Mol Med 2008; 14: 327-336. Go to original source... Go to PubMed...
  51. Hare JM, Loh E, Creager MA et al. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995; 92: 2198-2203. Go to original source... Go to PubMed...
  52. Schulz R, Dodge KL, Lopaschuk GD et al. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol 1997; 272: H1212-H1219. Go to original source... Go to PubMed...
  53. Chen Y, Traverse JH, Du R et al. Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 2002; 106: 273-279. Go to original source... Go to PubMed...
  54. Wink DA, Hanbauer I, Krishna MC et al. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1993; 90: 9813-9817. Go to original source... Go to PubMed...
  55. Nisoli E, Clementi E, Paolucci C et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003; 299: 896-899. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.